Rankings
▼
Calendar
ALT (Altimmune, Inc.) Stock Financials & Earnings | Market Cap Arena
ALT
Altimmune, Inc.
Mkt Cap
$353M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$41,000
Net Income (TTM)
-$88M
EPS (TTM)
-$1.01
Free Cash Flow (TTM)
-$68M
Gross Margin
-36451.2%
Op. Margin
-230461.0%
Net Margin
-214861.0%
FCF Margin
-165473.2%
P/S Ratio (TTM)
8599.7x
P/E Ratio (TTM)
—
YoY Rev Growth
+105.0%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$21K
$21K
-$22M
Q2 23
$6K
-$13M
-$18M
Q3 23
$362K
-$18M
-$23M
Q4 23
$37K
$37K
-$34M
Q1 24
$5K
-$102K
-$27M
Q2 24
$5K
$5K
-$27M
Q3 24
$5K
$5K
-$25M
Q4 24
$5K
$5K
-$25M
Q1 25
$5K
$5K
-$22M
Q2 25
$5K
$5K
-$23M
Q3 25
$5K
-$15M
-$21M
Q4 25
$26K
$0
-$29M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
—
—
Q2 23
—
—
Q3 23
1263.8x
—
Q4 23
827.7x
—
Q1 24
860.0x
—
Q2 24
862.1x
—
Q3 24
6780.5x
—
Q4 24
17629.4x
—
Q1 25
17629.4x
—
Q2 25
17629.4x
—
Q3 25
17629.4x
—
Q4 25
8599.7x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$19M
-$19M
Q2 23
-$20M
-$20M
Q3 23
-$20M
-$20M
Q4 23
-$17M
-$17M
Q1 24
-$16M
-$16M
Q2 24
-$18M
-$18M
Q3 24
-$27M
-$27M
Q4 24
-$18M
-$18M
Q1 25
-$17M
-$17M
Q2 25
-$20M
-$20M
Q3 25
-$12M
-$12M
Q4 25
-$19M
-$19M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$51K
Q2 23
$4K
Q3 23
$0
Q4 23
$0
Q1 24
$0
Q2 24
$0
Q3 24
$0
Q4 24
$0
Q1 25
$0
Q2 25
$10K
Q3 25
$0
Q4 25
$1K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-34.4%
+11.5%
Q2 23
-25.0%
-11.7%
Q3 23
+18000.0%
-7.5%
Q4 23
+133.6%
+46.4%
Q1 24
-76.2%
+23.0%
Q2 24
-16.7%
+48.5%
Q3 24
-98.6%
+8.2%
Q4 24
-86.5%
-26.1%
Q1 25
+0.0%
-18.6%
Q2 25
+0.0%
-14.3%
Q3 25
+0.0%
-15.8%
Q4 25
+420.0%
+16.3%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$3M
12738.1%
Q2 23
$0
0.0%
Q3 23
$3M
748.6%
Q4 23
$2M
6673.0%
Q1 24
$4M
73000.0%
Q2 24
$4M
86220.0%
Q3 24
$3M
61560.0%
Q4 24
$3M
67080.0%
Q1 25
$4M
80300.0%
Q2 25
$0
0.0%
Q3 25
$4M
71080.0%
Q4 25
$5M
19003.8%
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$17M
$5M
Q2 23
$13M
$5M
Q3 23
$18M
$5M
Q4 23
$17M
$4M
Q1 24
$21M
$5M
Q2 24
$21M
$6M
Q3 24
$20M
$5M
Q4 24
$20M
$5M
Q1 25
$16M
$6M
Q2 25
$17M
$6M
Q3 25
$15M
$6M
Q4 25
$18M
$11M
marketcaparena.com
Revenue Segments
Quarter
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$105M
$61M
$166M
Q2 23
$102M
$58M
$160M
Q3 23
$87M
$54M
$141M
Q4 23
$135M
$63M
$198M
Q1 24
$79M
$103M
$182M
Q2 24
$57M
$108M
$165M
Q3 24
$31M
$108M
$139M
Q4 24
$37M
$95M
$132M
Q1 25
$49M
$101M
$150M
Q2 25
$183M
$0
$183M
Q3 25
$61M
$150M
$211M
Q4 25
$44M
$230M
$273M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
50M
+0.2%
Q2 23
51M
+1.1%
Q3 23
54M
+5.8%
Q4 23
58M
+9.0%
Q1 24
71M
+21.1%
Q2 24
71M
+0.2%
Q3 24
71M
+0.2%
Q4 24
71M
+0.2%
Q1 25
76M
+6.0%
Q2 25
81M
+7.8%
Q3 25
89M
+9.7%
Q4 25
101M
+12.5%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$291K
35
FY 15
$967K
11
FY 16
$402K
13
FY 17
$1K
30
FY 18
$383K
27
FY 19
$232K
25
FY 20
$190K
43
FY 21
$94K
47
FY 22
-$1K
52
FY 23
$7K
59
FY 24
$339
59
FY 25
$0
200K
marketcaparena.com